<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Philpot, Benjamin</style></author><author><style face="normal" font="default" size="100%">McNamara, Kevin</style></author><author><style face="normal" font="default" size="100%">Dunbar, James A</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction</style></title><secondary-title><style face="normal" font="default" size="100%">British Journal of General Practice</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">180-180</style></pages><doi><style  face="normal" font="default" size="100%">10.3399/bjgp12X635994</style></doi><volume><style face="normal" font="default" size="100%">62</style></volume><issue><style face="normal" font="default" size="100%">597</style></issue><abstract><style  face="normal" font="default" size="100%">Brett et al recently described a randomised trial of cardiovascular disease (CVD) risk reduction in three general practices.1 Suboptimal trial design may be a substantial contributor of concern about the efficacy and cost-effectiveness of such primary prevention interventions by health professionals.2 We are concerned that such shortcomings also feature in their study.The study aimed to measure the effect on CVD risk of …</style></abstract></record></records></xml>